Welcome to the May 2017 edition of ReFlections, RGA’s
global medical newsletter.
This edition includes an update by
Dr. Elyssa Del Valle on the current role of genomics in breast
cancer management and its implications for insurance medicine.
Dr. Dave Rengachary’s article, which focuses on arteriovenous
malformations, simplifies the nomenclature of cerebral vascular
lesions and provides a risk stratification framework, and
Rebecca Abayakoon and Dr. Sheetal Salgaonkar provide a
comprehensive update on the role of human papillomavirus
testing in cervical cancer screening.
Rounding out this issue, The Longer Life Foundation report
focuses on research results of recent grant recipients and their
relevance to insurance medicine, and ReCite again presents
articles from recent medical literature that are essential reading
for underwriters, product developers, claims assessors, and
It is with mixed emotions that we announce that this is the last
issue of ReFlections for two members of our three-editor team,
as Neil Wilkinson, Vice President, Medical Services, and Dr.
Philip Smalley, Senior Vice President and Global Chief Medical
Officer, are both retiring in May 2017.
Neil and Phil's three decades in this industry (Neil as an
underwriter and Phil as a medical director) have seen
tremendous changes worldwide, both in the basic work of
underwriting and in the products insurers now sell to protect
customers. Technology and the philosophy of underwriting
are evolving with increasing speed, yielding exciting and
challenging times ahead. Stewardship of ReFlections will stay in the hands of Dr. Dan
Zimmerman, whose dedication and enthusiasm over the past
two years has brought new authors and a greater global focus
to ReFlections. Peter Barrett, who leads RGA's Global Claims,
Underwriting Quality & Risk Assurance, and Global Medical
Services, will join our editorial team with the next issue, and we
look forward to his contributions and expertise.
Inside this Issue